35 Leading Active Pharmaceutical Ingredient Companies Shaping Innovation and Market Growth
Discover the top 35 companies transforming the active pharmaceutical ingredient market, including Pfizer Inc., Divi’s Laboratories Limited, Asymchem Inc., and other industry leaders. Backed by a market projected to grow from $144.20 billion to $198.39 billion by 2030 at a CAGR of 6.6%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future...
29 Leading GLP-1 Analogues Companies Shaping Innovation and Market Growth
Discover the top 29 companies transforming the GLP-1 analogs market, including Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and other industry leaders. Backed by a market projected to grow from $64.42 billion to $170.75 billion by 2033 at a CAGR of 13.0%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the...
29 Leading Clinical Trial Services Companies Shaping Innovation and Market Growth
Discover the top 29 companies transforming the clinical trial services market, including IQVIA Inc., Icon PLC, Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $66.59 billion to $101.86 billion by 2030 at a CAGR of 8.9%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry....
25 Leading Drug Discovery Services Companies Shaping Innovation and Market Growth
Discover the top 25 companies transforming the drug discovery services market, including Thermo Fisher Scientific Inc., Charles River Laboratories, WuXi AppTec, and other industry leaders. Backed by a market projected to grow from $16.36 billion to $27.23 billion by 2030 at a CAGR of 10.7%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future...
30 Leading Biosimilars Companies Shaping Innovation and Market Growth
Discover the top 30 companies transforming the biosimilars market, including Sandoz Group AG, Pfizer Inc., Amgen Inc., and other industry leaders. Backed by a market projected to grow from $35.04 billion to $72.29 billion by 2035 at a CAGR of 7.5%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market...
36 Leading Pharmaceutical Contract Manufacturing Companies Shaping Innovation and Market Growth
Discover the top 36 companies transforming the pharmaceutical contract manufacturing market, including Thermo Fisher Scientific Inc., Lonza, Catalent, Inc., and other industry leaders. Backed by a market projected to grow from $209.90 billion to $311.95 billion by 2030 at a CAGR of 8.2%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future...
27 Leading Contract Research Organization Services Companies Shaping Innovation and Market Growth
Discover the top 27 companies transforming the contract research organization (CRO) services market, including IQVIA Inc., ICON plc, Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $84.61 billion to $125.95 billion by 2030 at a CAGR of 8.3%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the...
Pharmaceutical Drying Equipment Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global pharmaceutical drying equipment market was valued at US$5.45 billion in 2023 and US$5.80 billion in 2024. It is projected to grow at a CAGR of 7.1% from 2024 to 2029, reaching a forecasted valuation of US$8.18 billion by the end of the period. This growth is primarily fueled by the expansion of manufacturing facilities, rising demand for biopharmaceuticals, and the rapid development of...
Topical Drug Delivery Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global topical drug delivery market, valued at US$247.3 billion in 2024, is projected to advance at a resilient compound annual growth rate (CAGR) of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$408.97 billion by the end of the period. This growth is driven by the rising prevalence of dermatological disorders, a growing demand for non-invasive drug administration, and advancements...
The Global Pharmaceutical Contract Manufacturing Market Report 2026
The global pharmaceutical contract manufacturing market is projected to grow from USD 209.90 billion in 2025 to USD 311.95 billion by 2030, at a CAGR of 8.2%. Growth looks steady, but the drivers are quite specific. Capacity shortages in GLP-1 production, rising ADC pipelines, patent expiries, and demand for biosimilars are all pushing more work toward CDMOs.
Download PDF Report
Key takeaways
North...